CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
NeuroEPO in patients with Mild-Moderate Alzheimer's disease	01/02/2017	Registered
NeuroEPO in patients with Parkinson disease stage II-III	01/02/2017	Registered
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma	01/09/2016	Registered outdated
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.	01/10/2020	Registered outdated
NeuroEPO in stroke	02/08/2018	Registered
Phase I/II trial with the mutein no alfa of IL-2	03/02/2017	Registered outdated
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS)	03/03/2023	Registered
CIMAvax-EGF-Platelets-Adults- Lung Cancer	03/08/2018	Registered
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I	03/11/2017	Registered
Dose scale-up and cohort expansion with the therapeutic mAb 14F7	04/12/2015	Registered outdated
CIMAVax EGF in Lung Cancer in PHC. Phase IV	05/08/2014	Registered
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma	05/09/2017	Registered
Nimotuzumab cold kit for the immunodiagnosis of solid tumors	05/10/2018	Registered
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma	05/11/2013	Registered outdated
14F7 in chronic B-cell lymphoproliferative syndrome	07/03/2018	Registered
NGcGM3/VSSP in small cell lung cancer	07/12/2016	Registered outdated
NGcGM3/VSSP in Metastatic melanoma	07/12/2016	Registered
VSSP in renal cell carcinoma	08/04/2021	Registered
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer	08/07/2015	Registered
VSSP in metastasic renal cell carcinoma	08/08/2018	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources